As of Jul 27
| -0.021 / -1.15%|
The 2 analysts offering 12-month price forecasts for Windtree Therapeutics Inc have a median target of 5.65, with a high estimate of 8.00 and a low estimate of 3.30. The median estimate represents a +214.06% increase from the last price of 1.80.
The current consensus among 2 polled investment analysts is to Buy stock in Windtree Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.